EMA — authorised 31 October 2022
- Marketing authorisation holder: ASTRAZENECA AB
- Status: approved
🇪🇺 Beyfortus in European Union
EMA authorised Beyfortus on 31 October 2022
Marketing authorisation
Beyfortus in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Infectious Disease approved in European Union
Frequently asked questions
Is Beyfortus approved in European Union?
Yes. EMA authorised it on 31 October 2022.
Who is the marketing authorisation holder for Beyfortus in European Union?
ASTRAZENECA AB holds the EU marketing authorisation.